Dan Lemaitre Named CEO of BlueWind Medical

BlueWind Medical has announced the appointment of Dan Lemaitre as Chief Executive Officer (CEO) effective January 1st, 2020. Mr. Lemaitre has served as Chairman of the Board of BlueWind Medical since November 2018.

Dan Lemaitre is also a board member of Globus Medical and serves as Chairman of Endologix. Previous CEO stints for Dan Lemaitre included CoreValve, a pioneer in the transcatheter heart valve market, that was acquired by Medtronic for $800 Million. Prior to CoreValve, Lemaitre was Medtronic’s Senior Vice President of Strategy and Business Development. Earlier in his career, Lemaitre was a top-ranked medical device analyst initially at Cowen & Company, and later at Merrill Lynch.

“Dan Lemaitre is assuming the role of CEO at a critical time for the company and for the OAB market,” said Ilan Neugarten, Chairman of the board of Rainbow Medical, BlueWind Medical’s largest investor. “With his tremendous experience, Dan will help transform BlueWind from a technology stage company to a leading player in the neuromodulation market.”

BlueWind Medical has the potential to revolutionize the treatment of OAB which impairs the quality of life of millions of patients in the US and around the world,” said Dan Lemaitre. “Our RENOVA device, is easy to implant, potentially devoid of severe complications and is in a form factor that works for physicians and patients alike. With our technology and a spectacular team, we expect to help many patients with our technology that heretofore were not adequately treated with conservative or more invasive technologies.”

“We are excited about the potential for our technology and are looking forward to a successful journey with Dan’s leadership as we embark on our pivotal study at sites in Europe and the United States,” said Guri Oron, who served as CEO for the previous six years and will assume the role of President and General Manager.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy